Clinical Trial Update: Real-world Study of Lenalidomide After First-line Treatment Lenvatinib With PD-1 in Advanced HCC [NA]

View source ↗

Summary

This entry notes a completed real-world trial evaluating lenalidomide after first-line treatment with lenvatinib and a PD-1 inhibitor in advanced hepatocellular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenalidomide (Revlimid) (lenalidomide)
• Lenvatinib (Lenvima) (lenvatinib)

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: HCC - Hepatocellular Carcinoma | NA | Status: COMPLETED